Purchase Order 75D30124P20107

Award Date 9/18/24
Potential Completion Date 1/14/28
Potential Value $246K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Aurora, CO 80045, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to the University of Colorado-Denver, a major public research university, to conduct a comparison of immunological responses. The $75,000.00 firm fixed-price purchase order has a completion date of May 31, 2017 and was awarded on August 4, 2016 without any set-aside designation. The University of Colorado-Denver holds other federal contracts and grants, including an Indefinite Delivery Contract with...
This federal contract award, with ID HHSD200201692277C, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Colorado-Denver, doing business as The Regents of the University of Colorado, for the UTIDECIDE program. The $249,708 firm fixed-price definitive contract has an ultimate completion date of September 19, 2017 and was awarded on September 13, 2016. The contract does not have a set-aside designation. The University of Colorado-Denver is a major public...
This is a firm-fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Colorado-Denver to conduct an ENTEROVIRUS D68 SHEDDING STUDY. The contract, valued at $299,646.00, has a completion date of July 23, 2023 and does not have any set-aside designation. The University of Colorado-Denver is a major public research university that frequently receives federal funding through contracts and grants to support its research, education, and...
The University of Colorado Denver, known as the University of Colorado-Denver, was awarded a $11,755,165.47 cost-reimbursement contract by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The contract, which runs through February 2026, does not have a set-aside designation. The contract is a definitive contract for the university to provide a variety of services and conduct research across disciplines including medicine,...
The Regents of the University of Colorado, doing business as the University of Colorado Denver, was awarded a $90,000 firm fixed price purchase order by the Centers for Disease Control and Prevention to support research relating to the burden of foodborne illness. Performance will take place in Aurora, Colorado over a one-year period ending August 2024. As part of its mission to protect public health and safety, the CDC works to track and prevent foodborne disease through epidemiological...
This federal contract award is for a Definitive Contract with a Ceiling Value of $570,344,932.37, awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The contract is for "BIOMEDICAL (BASIC)" services and has an Ultimate Completion Date of December 31, 2011. The University of Colorado-Denver is a major public research university that...
This is a federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The $609,101 contract is for biomedical research and is a definitive contract with a cost-no-fee pricing type. The contract does not have a set-aside designation. The University of Colorado-Denver is a major public research university that frequently...
The University of Colorado-Denver, a major public research university, was awarded a $2,280 firm-fixed-price purchase order by the Department of Veterans Affairs to conduct coronavirus research and efficacy studies. The contract does not have a set-aside designation. The University of Colorado-Denver is known for its medical research and has held various federal contracts and grants to support its work across disciplines. This award is associated with the university's broader research...
The University of Colorado-Denver has been awarded a $119,515.54 delivery order contract by the National Institute of Child Health and Human Development, a civilian agency, to provide core function activities for the Contraceptive Clinical Trial Network - Female Sites. This delivery order is part of a larger Indefinite Delivery Contract the university holds to serve as a clinical research site for the National Institute on Alcohol Abuse and Alcoholism's Medications Development Clinical...
This is a delivery order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The $451,070 contract is for a randomized controlled clinical trial to evaluate the efficacy, safety, and acceptability of the female contraceptive C31G. The contract does not have any set-aside designations. The University of Colorado-Denver is a major public research...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract valued at $246,000.00 to the University of Colorado-Denver, a major public research university, for a project titled "RECTAL STUDY". The contract has an ultimate completion date of January 14, 2028 and was awarded on September 18, 2024. This award appears to be part of a larger Indefinite Delivery Contract (IDC) awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) to the university to serve as a clinical research site for medication development studies on alcohol use disorder treatments. The IDC has a $48 million ceiling value across multiple awardees and runs through March 2028. The University of Colorado-Denver is a large recipient of federal funding through contracts and grants to support its research, education, and public service missions, particularly in the medical and scientific fields.

Generated 1/14/25, 9:26 AM